ASCO

DCI Chief Patient Experience and Safety Officer Thomas LeBlanc, MD, has been named an ASCO Advocacy Champion and chair of the ASCO24 Annual Meeting Education Program Committee.

DCI cancer disparities and healthcare delivery researchers Steven Patierno, PhD, and Nadine Barrett, PhD, are part of national efforts to mitigate cancer health disparities.

Biostatistician Susan Halabi, PhD, presented at ASCO the results of her PCF-funded study that may ultimately help speed treatments to patients.

Congrats to Lucy Boyce Kennedy, MD & Divya Natesan, MD (right) who each received a Conquer Cancer 2021 ASCO Annual Meeting Merit Award!

DCI faculty Thomas Leblanc, MD, MA, MHS, FAAHPM, has been named a Fellow of the American Society of Clinical Oncology.

DCI faculty Daniel George, MD, has been named a Fellow of the American Society of Clinical Oncology.

For a second year, Arif Kamal, MD, MHS, MBA, FAAHPM, FASCO, has been named an ASCO Advocacy Champion.

Duke Cancer Institute will present more than 100 abstracts across multiple cancer types during the ASCO20 Virtual Scientific Program of the 2020 ASCO Annual Meeting.

Duke Cancer Institute member and family physician Kevin Oeffinger, MD, has been named a Fellow of the American Society of Clinical Oncology (FASCO).